Results 221 to 230 of about 47,775 (306)
Age-period-cohort effect on motor neuron disease mortality in the United States, 2001-2020. [PDF]
Raymond J +7 more
europepmc +1 more source
Engineered GM1 Intersects Between Mitochondrial and Synaptic Pathways to Ameliorate ALS Pathology
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease driven by genetic and molecular disruptions affecting energy balance, protein homeostasis, and stress responses in nerve cells. Studies using human and rodent models identified convergent defects in mitochondria and synaptic function.
Federica Pilotto +11 more
wiley +1 more source
Trans-Generational Morphological Trait Plasticity in Parthenogenetic Offspring of Two <i>Brachionus dorcas</i> Morphotypes Induced by <i>Asplanchna</i> Kairomones. [PDF]
Ge Y +6 more
europepmc +1 more source
Discovery of H2 Receptor Antagonists as Colistin Enhancers by Targeting Acid Stress Response
This study identifies YqgB as a key target for restoring colistin susceptibility in mcr‐positive pathogens under acidic conditions by remodeling phospholipid composition and reducing LPS modification. Deep learning‐based screening reveals H2 receptor antagonists as novel colistin adjuvants. Further investigations indicate that ranitidine and famotidine
Jinju Cai +7 more
wiley +1 more source
The Moderating Effect of Generation on the Association Between Long Working Hours and Mental Health: A Cross-Sectional Study of Korean Employees. [PDF]
Jung S +6 more
europepmc +1 more source
Schematic representation of ZIF‐8@OXA@inulin for cancer immunotherapy. Synthesis of ZIF‐8@OXA@inulin. Augmentation of pyroptosis, regulation of gut microbiota, and inhibition of NETs formation by ZIF‐8@OXA@inulin‐mediated comprehensive strategy for antitumor immune response. ABSTRACT Despite the potential of chemoimmunotherapy against colorectal cancer
Zhenhao Li +8 more
wiley +1 more source
Generational trends in reproductive factors among women in the US: implications for breast cancer incidence. [PDF]
Yang L, Toriola AT.
europepmc +1 more source

